{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:19Z","timestamp":1753890619033,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiometabolic disorders encompass a broad range of cardiovascular complications associated with metabolic dysfunction. These conditions have an increasing share in the health burden worldwide due to worsening endemic of hypertension, obesity, and diabetes. Previous studies have identified Tumor Protein p53-inducible Nuclear Protein 2 (Trp53inp2) as a molecular link between hyperglycemia and cardiac hypertrophy. However, its role in cardiac pathology has never been determined <jats:italic>in vivo<\/jats:italic>. In this study, we generated a cardiac specific knockout model of Trp53inp2 (Trp53inp2-cKO) and investigated the impact of Trp53inp2 inactivation on the pathogenesis of heart failure under mechanic or\/and metabolic stresses. Based on echocardiography assessment, inactivation of Trp53inp2 in heart led to accelerated onset of HFrEF in response to pressure-overload, with significantly reduced ejection fraction and elevated heart failure marker genes comparing to the control mice. In contrast, inactivation of Trp53inp2 ameliorated cardiac dysfunction induced by combined stresses of high fat diet and moderate pressure overload (Cardiometabolic Disorder Model). Moreover, Trp53inp2 inactivation led to reduced expression of glucose metabolism genes in lean, pressure-overloaded hearts. However, the same set of genes were significantly induced in the Trp53inp2-cKO hearts under both mechanical and metabolic stresses. In summary, we have demonstrated for the first time that cardiomyocyte Trp53inp2 has diametrically differential roles in the pathogenesis of heart failure and glucose regulation under mechanical vs. mechanical plus metabolic stresses. This insight suggests that Trp53inp2 may exacerbate the cardiac dysfunction during pressure overload injury but have a protective effect in cardiac diastolic function in cardiometabolic disease.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1226586","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T07:38:10Z","timestamp":1702885090000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic status differentiates Trp53inp2 function in pressure-overload induced heart failure"],"prefix":"10.3389","volume":"10","author":[{"given":"Jianfang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxun (Vincent)","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad","family":"Bouso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Mamlouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph D.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1559-4572.2009.00054.x","article-title":"Pathogenesis and pathophysiology of the cardiometabolic syndrome","volume":"11","author":"Kirk","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e005447","DOI":"10.1161\/CIRCIMAGING.117.005447","article-title":"Multiorgan, multimodality imaging in cardiometabolic disease","volume":"10","author":"Kumar","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00075197-200209000-00014","article-title":"Interaction between free fatty acids and glucose metabolism","volume":"5","author":"Boden","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","article-title":"Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models","volume":"42","author":"Withaar","year":"2021","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","article-title":"Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury","volume":"25","author":"Li","year":"2017","journal-title":"Cell Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2021.01.036","article-title":"Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia\/reperfusion injury","volume":"165","author":"Dambrova","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacbts.2018.11.001","article-title":"Glucagon receptor antagonism ameliorates progression of heart failure","volume":"4","author":"Gao","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e23944","DOI":"10.1371\/journal.pone.0023944","article-title":"A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genes","volume":"6","author":"Morton","year":"2011","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1371\/journal.pone.0001183","article-title":"Identification of a novel modulator of thyroid hormone receptor-mediated action","volume":"2","author":"Baumgartner","year":"2007","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/15548627.2016.1175693","article-title":"TP53INP2\/DOR, a mediator of cell autophagy, promotes rDNA transcription via facilitating the assembly of the POLR1\/RNA polymerase I preinitiation complex at rDNA promoters","volume":"12","author":"Xu","year":"2016","journal-title":"Autophagy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1080\/15548627.2019.1580510","article-title":"TP53INP2 contributes to autophagosome formation by promoting LC3-ATG7 interaction","volume":"15","author":"You","year":"2019","journal-title":"Autophagy"},{"key":"B17","doi-asserted-by":"publisher","first-page":"eabn4395","DOI":"10.1126\/scisignal.abn4395","article-title":"Coordinated activation of TGF-\u03b2 and BMP pathways promotes autophagy and limits liver injury after acetaminophen intoxication","volume":"15","author":"Stavropoulos","year":"2022","journal-title":"Sci Signal"},{"key":"B18","doi-asserted-by":"publisher","first-page":"H728","DOI":"10.1152\/ajpheart.00068.2016","article-title":"A systems genetics approach identifies Trp53inp2 as a link between cardiomyocyte glucose utilization and hypertrophic response","volume":"312","author":"Seldin","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","article-title":"Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible cre protein","volume":"89","author":"Sohal","year":"2001","journal-title":"Circ Res"},{"article-title":"Amyloid \u03b2 induces cardiac dysfunction and neuro-signaling impairment in the heart of an Alzheimer\u2019s disease model","year":"2023","author":"Andrea","key":"B20"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.cub.2010.08.055","article-title":"dDOR is an EcR coactivator that forms a feed-forward loop connecting insulin and ecdysone signaling","volume":"20","author":"Francis","year":"2010","journal-title":"Curr Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/embor.2009.242","article-title":"The nuclear cofactor DOR regulates autophagy in mammalian and Drosophila cells","volume":"11","author":"Mauvezin","year":"2010","journal-title":"EMBO Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1091\/mbc.e08-07-0671","article-title":"The TP53INP2 protein is required for autophagy in mammalian cells","volume":"20","author":"Nowak","year":"2009","journal-title":"Mol Biol Cell"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1226586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T07:38:14Z","timestamp":1702885094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1226586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2023.1226586"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1226586","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"article-number":"1226586"}}